OUR SCIENCE

Years of research experience has led to the generation of protocols to identify protein biomarkers of disease. Through robust sample management systems and optimised sample processing methods, biomarkers of disease can be identified, measured and reported. These methods are applied to a number of collaborative strategic research agreements by the Atturos scientific team to further our understanding of disease with one key aim in mind -  

to deliver advanced diagnostic tests and data of global impact
 

For more information on what we're currently working on, what's coming down the pipeline, and the projects we have completed, see below...

Lab_Blur.png

Active

Screening for the influence of endocrine disruptors on the male and female thyroid gland

in collaboration with the EU SCREENED consortium

Active

Identification of biomarkers for treatment responses in psoriatic arthritis patients

in collaborations with GRAPPA and Pfizer

Active

Validation of the PromarkerD diagnostic assay for diabetic kidney disease

in collaboration with Proteomics International

Upcoming

SOPHIA

in collaboration with GRAPPA

Active

Identification of biomarkers for joint damage in psoriatic arthritis patients

in collaboration with GRAPPA and Lilly

Completed

SoluTrypsin

in collaboration with Merck

 

 

 

 

Better clinical decisions leading to better patient outcomes

©2020 Atturos Ltd.